Hjem › Kardiovaskulær sykdom › Indiana › Indianapolis
Kliniske studier for Kardiovaskulær sykdom i Indianapolis, IN
17 studier for Kardiovaskulær sykdom søker deltakere på steder i og rundt Indianapolis (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
RekruttererFase 1/2Frivillige helsepersonell ønskes velkommen
- Innovative Hematology, Indianapolis
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RekruttererFase 2
- Franciscan Physician Network - Indiana Heart Physicians, Indianapolis
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RekruttererFase 3
- American Health Network - Avon, Avon · 13 mi unna
Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)
Rekrutterer
- Ascension Saint Vincent Hospital - Indianapolis, Indianapolis
Product Surveillance Registry
RekruttererObservasjonsstudie
- Indianapolis, Indianapolis
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RekruttererFase 3
- Clinical Trial Site, Avon · 13 mi unna
- Clinical Trial Site, Whiteland · 16 mi unna
Zenith® Fenestrated+ Clinical Study
Rekrutterer
- Methodist Hospital of Indiana, Indianapolis
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Rekrutterer
- Ascension St. Vincent Hospital - Indianapolis, Indianapolis
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RekruttererFase 3
- Krannert Institute of Cardiology, Indianapolis
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
RekruttererFase 4Frivillige helsepersonell ønskes velkommen
- Indianapolis VA Medical Center, Indianapolis
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RekruttererFase 3
- Research Site, Indianapolis
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RekruttererFase 3
- Franciscan Health Indianapolis, Indianapolis
- Ascension Saint Vincent Heart Center, Indianapolis
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Rekrutterer
- Ascension St. Vincent's, Indianapolis
Molecular Genetics of Heterotaxy and Related Congenital Heart Defects
RekruttererObservasjonsstudie
- Indiana University School of Medicine, Indianapolis
Pediatric Cardiomyopathy Mutation Analysis
RekruttererObservasjonsstudie
- IU School of Medicine, Indianapolis
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Rekrutterer
- St. Vincent Hospital, Indianapolis
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Rekrutterer
- Community Health Network, Indianapolis
Kardiovaskulær sykdom-studier i andre byer
- Boston, MA37 studier
- New York City, NY33 studier
- Washington, DC28 studier
- Houston, TX24 studier
- Dallas, TX23 studier
- Atlanta, GA22 studier
- Cleveland, OH22 studier
- Chicago, IL21 studier
- Philadelphia, PA21 studier
- Pittsburgh, PA20 studier
- St. Louis, MO20 studier
- Nashville, TN18 studier
Andre studier i Indianapolis
- Ikke-småcellet lungekreft32 studier
- Kreft (alle typer)24 studier
- Hjertesvikt23 studier
- Fedme20 studier
- Brystkreft20 studier
- Metastatisk kreft19 studier
- Kolorektal kreft18 studier
- Eggstokkreft17 studier
- Lungekreft16 studier
- Type 1-diabetes14 studier
- Endometriekreft14 studier
- Alzheimers sykdom14 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.